|
⚲
|
| Keyboard |
| Orth Andrew C
✚
|
|
|---|---|
| CIK # | 0001860010 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001860010] | |
| 4 | [0001860010] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Orth Andrew C | |
| Krystal Biotech Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Krystal Biotech Inc KRYS
Stock Option (Right to Buy) · derivative
|
2023-06-09 | Option exercise | 12,500 | $0.00 | |
|
Krystal Biotech Inc KRYS
Common Stock
|
2023-06-09 | Option exercise | 12,500 | $63.55 | 794,375 |
|
Krystal Biotech Inc KRYS
Common Stock
|
2023-06-09 | Sell | 6,906 | $128.94 | 890,460 |
|
Krystal Biotech Inc KRYS
Common Stock
|
2023-06-09 | Sell | 333 | $129.70 | 43,190 |
|
Krystal Biotech Inc KRYS
Common Stock
|
2023-06-09 | Sell | 5,261 | $128.10 | 673,934 |
|
Krystal Biotech Inc KRYS
Performance Stock Units · derivative
|
2023-02-28 | Grant | 10,000 | $0.00 | |
|
Krystal Biotech Inc KRYS
Stock Option (Right to Buy) · derivative
|
2023-02-28 | Grant | 20,000 | $0.00 | |
|
Krystal Biotech Inc KRYS
Stock Option (Right to Buy) · derivative
|
2022-02-28 | Grant | 50,000 | $0.00 | |
|
Krystal Biotech Inc KRYS
Stock Option (Right to Buy) · derivative
|
2021-05-31 | Grant | 205,000 | $0.00 |